Jeanne Hassebroek-Johnson, MD
Obstetrics & Gynecology · Sioux Falls, SDNPI 1740286491
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Daiichi Sankyo Inc. at 35.4% of the total. Reporting peaked in 2024 at $226 and has fallen 51.0% since, to $110 in 2025.
Across 51 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$301
- Bayer$57
- Novo Nordisk$56
- Biohaven Pharmaceutical Holding Company Ltd.$44
- Hologic Sales And Service, LLC$40
- AMAG Pharmaceuticals, Inc.$38
- plus $316 from 17 others
What the payments were for
- Food & beverage$81496%
- Education$384%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 16 | $301 |
| Bayer | 4 | $57 |
| Novo Nordisk | 4 | $56 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $44 |
| Hologic Sales And Service, LLC | 2 | $40 |
| AMAG Pharmaceuticals, Inc. | 3 | $38 |
| Astellas Pharma US Inc | 1 | $36 |
| Organon | 2 | $28 |
| Coopersurgical, Inc. | 1 | $26 |
| Amgen | 2 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Mallinckrodt Enterprises LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Pelvital USA, Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Monaghan Medical Corporation | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
| Covidien LP | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| AstraZeneca | 1 | $11 |
| AbbVie | 1 | $11 |
How this compares
$851 in reported general payments places this provider in the 75th percentile of 96 obstetrics & gynecology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Sioux Falls
- Ashley BriggsSioux Falls$15K
- Molly UhingSioux Falls$6K
- Abrea RoarkSioux Falls$5K
- Catherine SchiltzSioux Falls$3K
- Jessica PearsonSioux Falls$1K
- Emily WintertonSioux Falls$1K
- Kaylee RungeSioux Falls$1K
- Kelly TolleySioux Falls$990
- Christen DukeSioux Falls$843
- Elizabeth HultgrenSioux Falls$776
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.